| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4184040 | European Psychiatry | 2015 | 4 Pages |
Abstract
The aim of this open trial was to assess the antidepressant/anxiolytic effects of oxytocin used as an adjunct to antidepressant in treatment-resistant depression. Fourteen patients, who have not responded to 40 mg of escitalopram, received intranasal synthetic oxytocin during 4 weeks, in association with antidepressant. This is the first open trial study suggesting OT in association with escitalopram significantly reduced scores on Hamilton Depression Rating Scale.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
G. Scantamburlo, M. Hansenne, V. Geenen, J.J. Legros, M. Ansseau,